IP Library › Granted Patent US 9,295,731
Granted Patent B2
US 9,295,731 · App. 13/854,296 · Granted Mar 29, 2016

Cleavable drug conjugates, compositions thereof and methods of use

Inventor: Mark Quang Nguyen (San Jose, CA)
Assignee: Mark Quang Nguyen
A61K47/48284A61K45/06A61K47/4843A61K47/48061A61K47/48092A61K47/48246
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,295,731
App. No.
13/854,296
Granted
Mar 29, 2016
Kind
B2
Abstract

Base-labile crosslinkers, base-labile conjugates comprising such crosslinkers, methods of their synthesis and use are disclosed.

Claims (23)

1. A compound of Formula (II):

or a salt thereof, wherein:

each A 1 is independently a moiety selected from Formula (A 1 a1), Formula (A 1 a2), Formula (A 1 a3 ), formula (A 1 b1), Formula (A 1 b 2), Formula (A 1 c1 ), Formula (A 1 c2 ), Formula (A 1 c3). Formula (A 1 d1), Formula (A 1 d2), Formula (A 1 d3), Formula (A 1 e1). Formula A 1 f1 and Formula (A 1 f2):

wherein:

each R 8 and R 9 is independently selected from hydrogen, methyl, ethyl, n-propyl, isopropyl, phenyl, and benzyl;

each E is selected from F, Cl, Br, and I; and

each L 2 is selected from halogen, N-hydroxysuccinimidyl, substituted N -hydroxvsuccinimidyl, phenol-yl, substituted phenol-yl, hydroxybenzotriazolyl, substituted hydroxybenzotriazolyl, imidazolyl, and substituted imidazolyl;

each X 1 and X 3 is independently selected from a covalent bond, C 1-20 alkanediyl, substituted C 1-20 alkanediyl, C 1-20 heteroalkanediyl, substituted C 1-20 heteroalkanediyl, C 3-12 cycloalkanediyl, substituted C 3-12 cycloalkanediyl, C 3-12 heterocycloalkanediyl, substituted C hd 3-12 heterocycloalkanediyl, C 4-20 alkanecycloalkanediyl, substituted C 4-20 alkanecycloalkanediyl, C 4-20 heteroalkanecycloalkanediyl, substituted C 4-20 heteroalkanecycloalkanediyl, C 6-20 arenediyl, substituted C 6-20 arenediyl, C 6-20 heteroarenediyl, substituted C 6-20 heteroarenediyl, C 7-20 alkanearenediyl, substituted C 7-20 alkanearenediyl, C 6-20 heteroalkanearenediyl, substituted C 6-20 heteroalkanearenediyl, and —(CH 2 ) n1 —(CH 2 -CH 2 -O) n2 —(CH 2 ) n3 —, wherein:

each n1 and n3 is independently an integer selected from 0 to 5; and

each n2 is independently an integer selected from 1 to 25;

each X 2 is independently selected from a covalent bond, —O—,—S—,NH—,N═, —N═N—, N═CH—, —SO—, —SO 2 —, SO 2 NH—,—SS—,—C(O)—, —C(O)O—, —C(O)NH—,—C(O)S—, —C(O)NH—N═,—OP(O)(OH)O—,—OC(O)O—, —OC(O)NH—,—NHC(O)NH—, and—NHC(S)NH—;

each R 1 and R 2 is independently selected from hydrogen, C 1-6 alkyl, substituted C 1-6 alkyl, C 1-6 , heteroalkyl, substituted C 1-6 heteroalkyl, C 6-10 aryl, substituted C 6-10 aryl, C 6-10 heteroaryl, and substituted C 6-10 heteroaryl;

D is selected from aminopterin, folitixorin. methotrexate, pemetrexed, ralatrexate, raltitrexed, pelitrexol, talotrexin. deoxycoformycin, cladribine, clofarabine, fludarabine, thioguanine, mercaptopurine, berubicin daunorubicin, doxorubicin, epirubicin, idarubicin, amrubicin, pirarubicin, zorubicin mitoxantrone, banoxantrone, ledoxantrone, nortoixantrone, pixantrone, piroxantrone, sabarubicin, topixantrone, monomethyl, auristatin E, monomethyl, auristatin F, monomethyl, dolastatin, 10, dolastatin 15, belotecan, atiratecan, camptopthecin, exatecan, irinotecan, namitecan, rubitecan, topotecan, demecolcine, duocarmycin A, duocarmycin SA, duocarmycin B, duocarmycin B1 ,abbeymycin, anthramycin, centanamycin, chicamycin, mazethramycin, porothrarnycin A, porothramycin B, sibanomycin, sibiromycm, trabectedin, calicheamicin γ1, calicheamicin T, esperamicin Al, esperamicin C, esperamicin D, dynemicin A, dynemicin H, dynemicin M, dynemicin N, dynemicin O, dynemicin p, dynemicin Q, dynemicin S, neocarzinostatin chromophore, uncialamycin, 21-aminoepothilone B, eribulin, hemiasterlin, HTI-286, kahalatide F, elsamitrucin, lucanthone, melphalan, mitoguazone, nimustine, procarbazine, dacarbazine, amsacrine 5-amino-4-oxo-pentanoic acid. methyl 5-amino-4-oxo -pentanoate, actimomycin D, 7-aminoactinomycin D, bleomycin, mitomycin, staurosporine, desacetylvinblastine hydrazide, vinblastine, vincristine, vindesine, vinflunine, vinorelbine, afatinib, apilimbd, balamanimod, barasertib, bosutinib, ceanertinib, cevipabulin, crizotinib, dacomitinib, dasatinib, denibulin. dilmapimod, dinaciclib, dovitiriib, dutacatib, duvoglustat, edotecarin, elisidepsin, entinostat, epetirimod, erlotinib, fingolimod, fostamatinib, gefitinib, golotimod, gusperimus, imatinib, imiquimod, intedanib, ispinesib, lapatinib, lenalidomide, linifanib, litronesib, losmapimod, metesind, mocetinostat, motesanib, masitinib, myriocin, neratinib, nilotinib, odanacatib, ombrabulin, pamapimod, panobinostat, pazopanib, plerixafor, pomalidomide, razupenem, resiquimod, sabarubicin, saracatinib, seliciclib, selumetinib, sotirimod, squalamine, tacedinaline, talabostat, taltobulin, telatinib, tipifarnib, tozasertib, vandetanib, vatalanib, veliparib, voreloxin, alvespimycin, amikacin, amphotericin B, arbekacin, astromicin, bacitracin, balofloxacin, bederocin, bekanamycin, besifloxacin, brodimoprim, ciprofloxacin, clinafloxacin, colistin, daptomycin, dibekacin, enoxacin, framycetin, garenoxacin, gatifloxacin, gemifloxacin, gentamicin, gentamicin, grepafloxacin, hamycin, hexetidine, hygromycin B, ibacitabine, iclaprim, isepamicin, kanamycin, lomefloxacin, lucimycin, lymecycline, mepartricin, moxifloxacin, natamycin, nemonoxacin, neomycin B, neomycin C, netilmicin, norfloxacin, nystatin, omadacycline, oritavancin, paromomycin, pazufloxacin, perimycin A, perimycin B, perimycin C, pipemidic acid, polymyxin B, puromycin, radezolid, retaspimycin, ribostamycin, rimocidin, sisomicin, sitafloxacin, sparfloxacin, spectinomycin, streptomycin, sulfacetamide, sulfadiazine, sulfadimethoxine, sulfadimidine, sulfafurazole, sulfalene, sulfamazone, sulfamerazine, sulfamethizole, sulfamethoxazole, sulfamethoxypyridazine, sulfametomidine, sulfametoxydiazine, sulfametrole, sulfamoxole, sulfanilamide, sulfaperin, sulfaphenazole, sulfapyridine, sulfathiazole, sulfathiourea, sulfisomidine, teicoplanin, telavancin, tanespimycin, temafloxacin, tetroxoprim, tigecycline, tobramycin, tosufloxacin, trimethoprim, trimethoprim, trovafloxacin, tyrothricin, ulifloxacin, valnemulin, vancomycin, verdamicin, and zabofloxacin; and

n5 is an interger selected from 1to 20.

2. The compound of claim 1 , wherein each A 1 is independently a moiety selected from Formula (A 1 ala), Formula (A 1 a2a), Formula (A 1 a2b), Formula (A 1 a3a), Formula (A 1 a3b), Formula (A 1 b 1a), Formula (A 1 b1b), Formula (A 1 b1c), Formula (A 1 b2a), Formula (A 1 b2b), Formula (A 1 b 2c), Formula (A 1 c I), Formula (A 1 c2), Formula (A 1 c3), Formula (A 1 d1), Formula (A 1 d2), Formula (A 1 d3), Formula (A 1 c1), Formula (A 1 f1), and Formula (A 1 f2):

3. The compound of claim 1 . wherein each X 1 and X 3 is independently selected from a covalent bond, C 1-20 alkanediyl, C 1-20 cycloalkanediyl, C 6-10 arenediyl, C 7-20 alkanearenediyl, and —(CH 2 ) n1 —(CH 2 —CH 2 —O), n2 —(CH 2 ) n3 —, wherein each n1 and n3 is independently an integer selected from 0 to 5 and each n2 is independently an integer selected from 1 to 25.

4. The compound of claim 1 , wherein each X 1 and X 3 is independently selected from a covalent bond, methane-diyl, ethane-1 ,2-diyl, propane-1,3-diyl, butane-1,4-diyl, pentane-1,5-diyl, hexane-1,6-diyl, benzene-diyl, methylbenzene-diyl, ethylbenzene-diyl, propylbenzcne-diyl, methylcyclohexane-diyl, —(CH 2 ) 2 —(CH 2 —CH 2 —O)—, —(CH 2 ) 2 —(CH 2 —CH 2 —O) 2 —(CH 2 )—, and —(CH 2 ) 2 —(CH 2 —CH 2 —O) 3 —(CH 2 ) 2 —.

5. The compound of claim 1 , wherein each X 2 is selected from a covalent bond, —O—, —S—, —SO—, —SO 2 —, —SO,NH——SS—, —C(O)—, —C(O)O—, —C(O)NH—,C(O)NH—N═, —OC(O)NH—, and —NHC(O)NH—.

6. The compound of claim 1 , wherein each. X 2 is selected from a covalent bond, —O —, —SO 2 NH—, —SS—, —C(O)—, —C(O)O—, and —C(O)NH—.

7. The compound of claim 1 , wherein each R 1 and R 2 is independently selected from hydrogen, methyl, ethyl, propyl, isopropyl, and phenyl.

8. The compound of claim 1 , wherein the compound is selected from the compound of Formula (II-A-1), Formula (II-A-2), Formula (II-A-3), Formula (II-A-4), Formula (II-A-5), Formula (II-A-6), Formula (II-A-7), Formula (II-A-8), Formula (II-A-9), and Formula (II-A-10):

9. The compound of claim 1 , wherein the compound is selected from the compound of Formula (II-B-1), Formula (II-B-2), Formula (II-B-3 ), Formula (II-B-4), Formula (II-B-5), Formula (II-B-6), Formula (II-B-7), Formula (II-B-8), Formula (II-B-9), Formula (II-B-10). Formula (II-B-1 1), Formula (II-13-1 and Formula (II-B-13):

10. The compound of claim 1 , wherein the compound is selected from Formula (II-a), Formula (II-b), Formula (II-c), Formula (II-d), Formula (II-e), Formula (II-f), Formula (II-g), Formula (II-h), Formula (II-i), Formula (II-j), Formula (II-k), Formula (II-l). Formula (II-m), Formula (II-n), Formula (II-o), Formula (II-p), Formula (II-q), Formula (II-r ), Formula (II-s), Formula (II-t), Formula (II-u), Formula (II-v), Formula (II-w), Formula (II-x), Formula (II-y), Formula (II-z), Formula (II-aa), Formula (II-ab), and Formula (II-ac), or a salt of any of the foregoing:

Continuity (1)
Related Publication 20140294851A1 · Oct 2, 2014